Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wound dressings that trap microbes: scientists test a Drug-Free approach

NCT ID NCT05089890

Knowledge-focused Sponsor: ABIGO Medical AB Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers are investigating whether wound dressings coated with dialkylcarbamoyl chloride (DACC) can bind bacteria and fungi from hard-to-heal wounds. The study enrolls 30 adults with wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, or arterial leg ulcers that have not healed for at least six weeks. Participants use one of three DACC-coated dressings, and researchers measure the microbes attached to the dressing after two days using genetic sequencing and electron microscopy. The goal is to understand how well the dressings capture microbes, not to compare the dressings against each other.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
DACC-coated wound dressings (Sorbact Compress, Gel Dressing, Ribbon Gauze)
What this could lead to
If the dressings bind microbes as intended, this could support a drug-free way to manage hard-to-heal wounds and reduce reliance on antibiotics.
What could go wrong
This is a small, exploratory study with 30 participants and no comparison group, so it cannot prove that the dressings improve healing. The findings may not apply to all wound types or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Able to read and understand the Subject Information and Informed Consent Form and provide meaningful informed consent 2. Due to start using one of the following dressings: Sorbact® Compress, Sorbact® Gel Dressing and Sorbact® Ribbon Gauze 3. Age ≥18 years 4. Presence of hard-to-heal wound for ≥6 weeks with no significant wound area reduction for the last 4 weeks confirmed by investigator/study nurse Exclusion Criteria: 1. Participating in another clinical investigation 2. Known allergy or sensitivity to any components of the allocated investigational device 3. Use of antimicrobial agent (e.g., silver- or iodine-containing dressings, or gels) during the last wo weeks 4. Use of a dressing from the Sorbact® range during the last two weeks 5. Subjects with any other condition that as judged by the investigator may make investigation procedures inappropriate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arterial leg ulcer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

decubitus ulcer Diabetic Foot ulcer of lower limbs Varicose Ulcer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arterial leg ulcer Diabetic foot ulcer Hard-to-heal wounds Pressure ulcer Venous leg ulcer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Sahlgrenska University Hospital

    RECRUITING

    Mölndal, 43143, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.